- Home
- DB vs GEHC Comparison
DB vs GEHC Comparison
Compare DB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DB
- GEHC
- Stock Information
- Founded
- DB 1870
- GEHC 1892
- Country
- DB Germany
- GEHC United States
- Employees
- DB N/A
- GEHC N/A
- Industry
- DB Major Banks
- GEHC Computer Software: Prepackaged Software
- Sector
- DB Finance
- GEHC Technology
- Exchange
- DB Nasdaq
- GEHC Nasdaq
- Market Cap
- DB 33.6B
- GEHC 37.5B
- IPO Year
- DB N/A
- GEHC N/A
- Fundamental
- Price
- DB $17.17
- GEHC $77.09
- Analyst Decision
- DB Buy
- GEHC Buy
- Analyst Count
- DB 2
- GEHC 13
- Target Price
- DB N/A
- GEHC $95.46
- AVG Volume (30 Days)
- DB 1.3M
- GEHC 3.2M
- Earning Date
- DB 01-30-2025
- GEHC 10-30-2024
- Dividend Yield
- DB 2.85%
- GEHC 0.16%
- EPS Growth
- DB N/A
- GEHC 8.27
- EPS
- DB 2.11
- GEHC 3.65
- Revenue
- DB $30,817,532,890.00
- GEHC $19,559,000,000.00
- Revenue This Year
- DB N/A
- GEHC $2.72
- Revenue Next Year
- DB $3.26
- GEHC $4.08
- P/E Ratio
- DB $7.90
- GEHC $21.12
- Revenue Growth
- DB 1.70
- GEHC 1.43
- 52 Week Low
- DB $12.43
- GEHC $71.31
- 52 Week High
- DB $18.07
- GEHC $94.55
- Technical
- Relative Strength Index (RSI)
- DB 47.22
- GEHC 26.13
- Support Level
- DB $17.68
- GEHC $80.47
- Resistance Level
- DB $18.05
- GEHC $81.78
- Average True Range (ATR)
- DB 0.24
- GEHC 1.43
- MACD
- DB 0.00
- GEHC -0.27
- Stochastic Oscillator
- DB 30.24
- GEHC 1.68
About DB Deutsche Bank AG
Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).